facebook    twitter    linkedin
Human FcgR3a (F158) / CD16a (F158) NF-AT Luci Jurkat Cell Line

Human FcgR3a (F158) / CD16a (F158) NF-AT Luci Jurkat Cell Line

Cat. # Size
CELL470 1 Vial

PRODUCT INFORMATION

Product Name
Human FcgR3a (F158) / CD16a (F158) NF-AT Luci Jurkat Cell Line
Link To
Cell Products
Expression System
Mammalian Expression System
Concentration
Approximately 5 × 106 cells/vial
Application
This reporter gene cell line is suitable for a broad range of applications, including functional characterization of target-mediated signaling pathways, quantitative analysis of pathway activation or inhibition, and ligand screening. The reporter system enables sensitive and reproducible readouts of cellular responses, supporting assay development, compound screening, and pharmacological profiling. This cell line can also be applied in drug discovery, target validation, and mechanism-of-action (MoA) studies.
Cell Strain
Jurkat
Form
Frozen
Species
Human
Growth Conditions
1640 + 10% FBS + 2 μg/mL Puromycin + 500 μg/mL Hygromycin B
Morphology
lymphoblast
Growth Properties
Suspended
Fluorescent Tag
Luci
Mycoplasma Status
Negative
Storage
90 % FBS + 10 % DMSO
Vapor phase of liquid nitrogen
Shipping Conditions
Dry Ice
Target
FcgR3a / CD16a
Description
The antibody exhibited potent ADCC activity as evaluated using the human FcgR3a (F158) / CD16a (F158) NF-AT Luci Jurkat cell line. The IC50 value was determined to be 0.23910 µg/mL.
Biosafety Level
1
Industry Terms
Not Available to Industry
CONTACT OUR TEAM